The Spectator

Portrait of the week: Alex Salmond’s party, China’s H&M ban and protests in Bristol and Batley

issue 03 April 2021

Home

More than 30 million had received their first dose vaccination. The government remained confident of supplying second doses and of vaccinating all the adult population by July, despite a delay in supplies from India and threats from the EU to stop exports. In response to EU hostility, Boris Johnson, the Prime Minister, said: ‘Companies may look at such actions and draw conclusions about whether or not it is sensible to make future investments.’ The Novavax vaccine, more than 50 million doses of which would be available if approved by the MHRA, would be made and packaged entirely in Britain. The Moderna vaccine was also expected to be available from the end of April. Third-dose vaccinations were planned from September for the over-seventies to meet the danger from variants. At dawn on 28 March, total UK deaths (within 28 days of testing positive for coronavirus) had stood at 126,573, a rise of 452 in the preceding week.

Comments

Join the debate for just $5 for 3 months

Be part of the conversation with other Spectator readers by getting your first three months for $5.

Already a subscriber? Log in